- Janice Tanne
- New York
Subsidies for combination treatments in countries where malaria is endemic are urgently needed to forestall drug resistance and save lives, warns a paper published this week.
A subsidy of only $100m (£57m; €83m) to $200m for artemisinin based combination drugs might be needed, said Ramanan Laxminarayan, from Resources for the Future, a non-profit, independent organisation based in Washington, DC, and the paper's lead author.
He said that if such a subsidy programme was implemented within three months, up to 25 000 lives a month could be saved (Health Affairs2006;25:325-36).
Dr Laxminarayan, whose …